cERBB-2/HER-2neu overexpression and its prognostic significance in uterine carcinosarcoma


Creative Commons License

Semiz H. S., Pala E. E., Can B., Atag E., Gungor H., Ellidokuz H., ...Daha Fazla

ESMO Targeted Anticancer Therapies Congress (TAT), ELECTR NETWORK, 7 - 08 Mart 2022, cilt.33, (Özet Bildiri) identifier